Form 4: BioLife Solutions CHRO Sells Shares for Tax Obligations

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 946 shares of common stock in December 2025 to satisfy tax withholding obligations from restricted stock vesting.

Summary

• Sarah Aebersold, Chief Human Resources Officer of BIOLIFE SOLUTIONS INC (BLFS), reported two sales of common stock.
• On December 9, 2025, 233 shares were sold at a price of $25.13 per share.
• On December 15, 2025, an additional 713 shares were sold at a price of $24.46 per share.
• The total number of shares sold across both transactions is 946.
• Following these transactions, Sarah Aebersold beneficially owns 76,006 shares of common stock.
• These sales were executed pursuant to a Rule 10b5-1(c) trading plan adopted on March 8, 2024.
• The purpose of the sales was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a pre-planned, non-discretionary sale for tax purposes, which does not reflect a change in management's confidence in the company's future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine disclosure for a corporate officer and does not provide specific insights into broader industry trends or competitive landscape. It reflects standard compensation and tax management practices within publicly traded companies.

Stakeholder Impact

• Shareholders: The impact on shareholders is minimal as these are routine, non-discretionary sales for tax purposes by an executive, not indicative of a change in company fundamentals or management's view of the stock's value.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

The reported sales by the Chief Human Resources Officer are routine, non-discretionary transactions executed under a Rule 10b5-1 plan to cover tax obligations related to restricted stock vesting. Such sales do not typically signal a change in the company's fundamentals or management's confidence, thus warranting a 'hold' recommendation as this specific filing does not provide new information to alter an investment thesis.

Keywords

BIOLIFE SOLUTIONS, BLFS, Form 4, insider transaction, stock sale, tax withholding, restricted stock, 10b5-1 plan